Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420756 · ClinicalTrials.gov registry record
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
A clinical trial of Mild Cognitive Impairment and Dementia, sponsored by American College of Radiology.
- Completed
- Registry status
- 18,488
- Enrollment target
- 2
- Study locations
NCT02420756: Completed study of Mild Cognitive Impairment and Dementia, sponsored by American College of Radiology.
NCT02420756 is a study of Mild Cognitive Impairment and Dementia that has completed, run by American College of Radiology. The registered enrollment target is 18,488 participants, above the 1,180-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (1467% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02420756, a study of Mild Cognitive Impairment and Dementia, has completed, sponsored by American College of Radiology.
- COMPLETED
- Registry status
- 18,488 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. The study will be performed in accordance with the Center for Medicare \& Medicaid Services (CMS) policy of Coverage with Evidence Development (CED) in Medicare beneficiaries who meet the Appropriate Use Criteria (AUC) for amyloid PET (Johnson et al. 2013). Our hypothesis is that amyloid PET will decrease uncertainty and increase confidence in the underlying cause of cognitive impairment, that this will translate into earlier counseling and interventions in these domains, and that these interventions will lead to improved outcomes.
Primary Outcome
Test whether amyloid PET imaging will lead to a ≥ 30% change between intended and actual patient management within 90 days in a composite measure of at least one of the following: 1. AD drug therapy; 2. Other drug therapy; and 3. Counseling about safety and future planning.
Conditions Studied
Interventions
- DEVICE PET Scan
Study Locations (2)
Pennsylvania
- American College of Radiology Imaging Network - Philadelphia
- Https://Www.Ideas-Study.Org/Site-Locator/ - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,488 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-12 |
What the finished NCT02420756 record still lists
NCT02420756 is an observational study that tracks outcomes without assigning an intervention. Its 18,488 participants enrollment target places it among the larger protocols in the corpus, above the 1,180-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (1467% higher).
The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which PET Scan is the first listed.
NCT02420756 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02420756 about?
NCT02420756 is a clinical study titled "Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study". The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. The study will be performed in accordance with the Center for Medicare \& Medicaid Services (CMS) policy of Coverage with ...
What is the current status of trial NCT02420756?
This trial is currently completed. The enrollment target is 18,488 participants. The study started on 2016-02. Estimated completion is 2017-12.
What conditions does trial NCT02420756 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Alzheimers Disease.
What interventions are being tested in trial NCT02420756?
The interventions under investigation include: PET Scan (DEVICE).
Who is sponsoring clinical trial NCT02420756?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02420756 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02420756's enrollment target sits among peer trials
18,488 2nd of 205 the highest of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia